nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—ADRA1B—vas deferens—testicular cancer	0.279	0.835	CbGeAlD
Dextroamphetamine—SLC18A2—testis—testicular cancer	0.0109	0.0325	CbGeAlD
Dextroamphetamine—SLC6A2—gonad—testicular cancer	0.00919	0.0275	CbGeAlD
Dextroamphetamine—SLC6A3—testis—testicular cancer	0.00821	0.0246	CbGeAlD
Dextroamphetamine—SLC18A2—lymph node—testicular cancer	0.00787	0.0236	CbGeAlD
Dextroamphetamine—SLC6A2—testis—testicular cancer	0.00663	0.0198	CbGeAlD
Dextroamphetamine—SLC6A2—lymph node—testicular cancer	0.0048	0.0144	CbGeAlD
Dextroamphetamine—CYP2D6—female gonad—testicular cancer	0.00409	0.0122	CbGeAlD
Dextroamphetamine—CYP2D6—testis—testicular cancer	0.00363	0.0109	CbGeAlD
Dextroamphetamine—Chest pain—Bleomycin—testicular cancer	0.0029	0.00435	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Etoposide—testicular cancer	0.00288	0.00433	CcSEcCtD
Dextroamphetamine—Decreased appetite—Vinblastine—testicular cancer	0.00286	0.00429	CcSEcCtD
Dextroamphetamine—Urticaria—Chlorambucil—testicular cancer	0.00285	0.00428	CcSEcCtD
Dextroamphetamine—Abdominal pain—Chlorambucil—testicular cancer	0.00284	0.00426	CcSEcCtD
Dextroamphetamine—Body temperature increased—Chlorambucil—testicular cancer	0.00284	0.00426	CcSEcCtD
Dextroamphetamine—Constipation—Vinblastine—testicular cancer	0.00281	0.00423	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Bleomycin—testicular cancer	0.00278	0.00417	CcSEcCtD
Dextroamphetamine—Infection—Bleomycin—testicular cancer	0.00276	0.00415	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Vinblastine—testicular cancer	0.00269	0.00404	CcSEcCtD
Dextroamphetamine—Agitation—Ifosfamide—testicular cancer	0.00267	0.00402	CcSEcCtD
Dextroamphetamine—Angioedema—Ifosfamide—testicular cancer	0.00266	0.00399	CcSEcCtD
Dextroamphetamine—Anorexia—Bleomycin—testicular cancer	0.00265	0.00398	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Chlorambucil—testicular cancer	0.00265	0.00397	CcSEcCtD
Dextroamphetamine—Abdominal pain—Vinblastine—testicular cancer	0.0026	0.00391	CcSEcCtD
Dextroamphetamine—Asthenia—Chlorambucil—testicular cancer	0.00258	0.00387	CcSEcCtD
Dextroamphetamine—Infection—Dactinomycin—testicular cancer	0.00257	0.00387	CcSEcCtD
Dextroamphetamine—Palpitations—Ifosfamide—testicular cancer	0.00257	0.00386	CcSEcCtD
Dextroamphetamine—Convulsion—Ifosfamide—testicular cancer	0.00252	0.00379	CcSEcCtD
Dextroamphetamine—Hypertension—Ifosfamide—testicular cancer	0.00251	0.00377	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Etoposide—testicular cancer	0.0025	0.00375	CcSEcCtD
Dextroamphetamine—Dyspnoea—Bleomycin—testicular cancer	0.00248	0.00372	CcSEcCtD
Dextroamphetamine—Chest pain—Ifosfamide—testicular cancer	0.00248	0.00372	CcSEcCtD
Dextroamphetamine—Anorexia—Dactinomycin—testicular cancer	0.00247	0.00371	CcSEcCtD
Dextroamphetamine—Diarrhoea—Chlorambucil—testicular cancer	0.00246	0.00369	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Vinblastine—testicular cancer	0.00242	0.00364	CcSEcCtD
Dextroamphetamine—Decreased appetite—Bleomycin—testicular cancer	0.00242	0.00363	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Ifosfamide—testicular cancer	0.00238	0.00357	CcSEcCtD
Dextroamphetamine—Asthenia—Vinblastine—testicular cancer	0.00236	0.00354	CcSEcCtD
Dextroamphetamine—Infection—Ifosfamide—testicular cancer	0.00236	0.00354	CcSEcCtD
Dextroamphetamine—Tremor—Cisplatin—testicular cancer	0.00235	0.00353	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Methotrexate—testicular cancer	0.00233	0.0035	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Ifosfamide—testicular cancer	0.0023	0.00345	CcSEcCtD
Dextroamphetamine—Vomiting—Chlorambucil—testicular cancer	0.00228	0.00343	CcSEcCtD
Dextroamphetamine—Anorexia—Ifosfamide—testicular cancer	0.00226	0.0034	CcSEcCtD
Dextroamphetamine—Decreased appetite—Dactinomycin—testicular cancer	0.00225	0.00338	CcSEcCtD
Dextroamphetamine—Diarrhoea—Vinblastine—testicular cancer	0.00225	0.00338	CcSEcCtD
Dextroamphetamine—Fatigue—Dactinomycin—testicular cancer	0.00223	0.00336	CcSEcCtD
Dextroamphetamine—Urticaria—Bleomycin—testicular cancer	0.00221	0.00331	CcSEcCtD
Dextroamphetamine—Body temperature increased—Bleomycin—testicular cancer	0.0022	0.0033	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Epirubicin—testicular cancer	0.00218	0.00328	CcSEcCtD
Dextroamphetamine—Irritability—Methotrexate—testicular cancer	0.00218	0.00328	CcSEcCtD
Dextroamphetamine—Dizziness—Vinblastine—testicular cancer	0.00218	0.00327	CcSEcCtD
Dextroamphetamine—Convulsion—Cisplatin—testicular cancer	0.00217	0.00326	CcSEcCtD
Dextroamphetamine—Mood swings—Methotrexate—testicular cancer	0.00217	0.00325	CcSEcCtD
Dextroamphetamine—Nausea—Chlorambucil—testicular cancer	0.00213	0.0032	CcSEcCtD
Dextroamphetamine—Anxiety—Cisplatin—testicular cancer	0.00213	0.0032	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00212	0.00318	CcSEcCtD
Dextroamphetamine—Dyspnoea—Ifosfamide—testicular cancer	0.00212	0.00318	CcSEcCtD
Dextroamphetamine—Somnolence—Ifosfamide—testicular cancer	0.00211	0.00317	CcSEcCtD
Dextroamphetamine—Affect lability—Epirubicin—testicular cancer	0.00211	0.00316	CcSEcCtD
Dextroamphetamine—Vomiting—Vinblastine—testicular cancer	0.00209	0.00314	CcSEcCtD
Dextroamphetamine—Decreased appetite—Ifosfamide—testicular cancer	0.00206	0.0031	CcSEcCtD
Dextroamphetamine—Headache—Vinblastine—testicular cancer	0.00206	0.0031	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.00206	0.00309	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00205	0.00308	CcSEcCtD
Dextroamphetamine—Body temperature increased—Dactinomycin—testicular cancer	0.00205	0.00308	CcSEcCtD
Dextroamphetamine—Abdominal pain—Dactinomycin—testicular cancer	0.00205	0.00308	CcSEcCtD
Dextroamphetamine—Fatigue—Ifosfamide—testicular cancer	0.00205	0.00307	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Cisplatin—testicular cancer	0.00205	0.00307	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Bleomycin—testicular cancer	0.00205	0.00307	CcSEcCtD
Dextroamphetamine—Infection—Cisplatin—testicular cancer	0.00203	0.00305	CcSEcCtD
Dextroamphetamine—Constipation—Ifosfamide—testicular cancer	0.00203	0.00305	CcSEcCtD
Dextroamphetamine—Mood swings—Epirubicin—testicular cancer	0.00203	0.00304	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Doxorubicin—testicular cancer	0.00202	0.00303	CcSEcCtD
Dextroamphetamine—Tachycardia—Cisplatin—testicular cancer	0.002	0.003	CcSEcCtD
Dextroamphetamine—Asthenia—Bleomycin—testicular cancer	0.00199	0.00299	CcSEcCtD
Dextroamphetamine—Convulsion—Etoposide—testicular cancer	0.00199	0.00299	CcSEcCtD
Dextroamphetamine—Hypertension—Etoposide—testicular cancer	0.00198	0.00298	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Cisplatin—testicular cancer	0.00198	0.00297	CcSEcCtD
Dextroamphetamine—Chest pain—Etoposide—testicular cancer	0.00196	0.00294	CcSEcCtD
Dextroamphetamine—Nausea—Vinblastine—testicular cancer	0.00195	0.00293	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Epirubicin—testicular cancer	0.00195	0.00293	CcSEcCtD
Dextroamphetamine—Anorexia—Cisplatin—testicular cancer	0.00195	0.00293	CcSEcCtD
Dextroamphetamine—Affect lability—Doxorubicin—testicular cancer	0.00195	0.00293	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00194	0.00292	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.00193	0.00289	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Dactinomycin—testicular cancer	0.00191	0.00287	CcSEcCtD
Dextroamphetamine—Urticaria—Ifosfamide—testicular cancer	0.00189	0.00283	CcSEcCtD
Dextroamphetamine—Body temperature increased—Ifosfamide—testicular cancer	0.00188	0.00282	CcSEcCtD
Dextroamphetamine—Abdominal pain—Ifosfamide—testicular cancer	0.00188	0.00282	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Etoposide—testicular cancer	0.00188	0.00282	CcSEcCtD
Dextroamphetamine—Mood swings—Doxorubicin—testicular cancer	0.00188	0.00282	CcSEcCtD
Dextroamphetamine—Infection—Etoposide—testicular cancer	0.00186	0.0028	CcSEcCtD
Dextroamphetamine—Asthenia—Dactinomycin—testicular cancer	0.00186	0.00279	CcSEcCtD
Dextroamphetamine—Tachycardia—Etoposide—testicular cancer	0.00183	0.00275	CcSEcCtD
Dextroamphetamine—Dyspnoea—Cisplatin—testicular cancer	0.00183	0.00274	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Methotrexate—testicular cancer	0.00182	0.00273	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Etoposide—testicular cancer	0.00181	0.00272	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Doxorubicin—testicular cancer	0.00181	0.00271	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Methotrexate—testicular cancer	0.0018	0.00271	CcSEcCtD
Dextroamphetamine—Anorexia—Etoposide—testicular cancer	0.00179	0.00268	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.00178	0.00268	CcSEcCtD
Dextroamphetamine—Decreased appetite—Cisplatin—testicular cancer	0.00178	0.00267	CcSEcCtD
Dextroamphetamine—Diarrhoea—Dactinomycin—testicular cancer	0.00177	0.00266	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00177	0.00265	CcSEcCtD
Dextroamphetamine—Vomiting—Bleomycin—testicular cancer	0.00177	0.00265	CcSEcCtD
Dextroamphetamine—Depression—Methotrexate—testicular cancer	0.00176	0.00264	CcSEcCtD
Dextroamphetamine—Rash—Bleomycin—testicular cancer	0.00175	0.00263	CcSEcCtD
Dextroamphetamine—Dermatitis—Bleomycin—testicular cancer	0.00175	0.00263	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Ifosfamide—testicular cancer	0.00175	0.00263	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00175	0.00262	CcSEcCtD
Dextroamphetamine—Asthenia—Ifosfamide—testicular cancer	0.0017	0.00256	CcSEcCtD
Dextroamphetamine—Sweating—Methotrexate—testicular cancer	0.00169	0.00254	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Epirubicin—testicular cancer	0.00169	0.00253	CcSEcCtD
Dextroamphetamine—Weight decreased—Epirubicin—testicular cancer	0.00167	0.00251	CcSEcCtD
Dextroamphetamine—Dyspnoea—Etoposide—testicular cancer	0.00167	0.00251	CcSEcCtD
Dextroamphetamine—Somnolence—Etoposide—testicular cancer	0.00167	0.0025	CcSEcCtD
Dextroamphetamine—Nausea—Bleomycin—testicular cancer	0.00165	0.00248	CcSEcCtD
Dextroamphetamine—Vomiting—Dactinomycin—testicular cancer	0.00165	0.00247	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00163	0.00245	CcSEcCtD
Dextroamphetamine—Rash—Dactinomycin—testicular cancer	0.00163	0.00245	CcSEcCtD
Dextroamphetamine—Decreased appetite—Etoposide—testicular cancer	0.00163	0.00245	CcSEcCtD
Dextroamphetamine—Diarrhoea—Ifosfamide—testicular cancer	0.00163	0.00244	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Etoposide—testicular cancer	0.00162	0.00243	CcSEcCtD
Dextroamphetamine—Body temperature increased—Cisplatin—testicular cancer	0.00162	0.00243	CcSEcCtD
Dextroamphetamine—Fatigue—Etoposide—testicular cancer	0.00162	0.00243	CcSEcCtD
Dextroamphetamine—Constipation—Etoposide—testicular cancer	0.0016	0.00241	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Epirubicin—testicular cancer	0.0016	0.00241	CcSEcCtD
Dextroamphetamine—Sweating—Epirubicin—testicular cancer	0.00158	0.00237	CcSEcCtD
Dextroamphetamine—Dizziness—Ifosfamide—testicular cancer	0.00157	0.00236	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00156	0.00234	CcSEcCtD
Dextroamphetamine—Weight decreased—Doxorubicin—testicular cancer	0.00155	0.00232	CcSEcCtD
Dextroamphetamine—Nausea—Dactinomycin—testicular cancer	0.00154	0.00231	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Etoposide—testicular cancer	0.00153	0.0023	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00151	0.00227	CcSEcCtD
Dextroamphetamine—Vomiting—Ifosfamide—testicular cancer	0.00151	0.00227	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Cisplatin—testicular cancer	0.00151	0.00227	CcSEcCtD
Dextroamphetamine—Rash—Ifosfamide—testicular cancer	0.0015	0.00225	CcSEcCtD
Dextroamphetamine—Dermatitis—Ifosfamide—testicular cancer	0.0015	0.00225	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Methotrexate—testicular cancer	0.0015	0.00225	CcSEcCtD
Dextroamphetamine—Urticaria—Etoposide—testicular cancer	0.00149	0.00224	CcSEcCtD
Dextroamphetamine—Abdominal pain—Etoposide—testicular cancer	0.00148	0.00223	CcSEcCtD
Dextroamphetamine—Body temperature increased—Etoposide—testicular cancer	0.00148	0.00223	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Doxorubicin—testicular cancer	0.00148	0.00223	CcSEcCtD
Dextroamphetamine—Asthenia—Cisplatin—testicular cancer	0.00147	0.00221	CcSEcCtD
Dextroamphetamine—Sweating—Doxorubicin—testicular cancer	0.00146	0.0022	CcSEcCtD
Dextroamphetamine—Nausea—Ifosfamide—testicular cancer	0.00141	0.00212	CcSEcCtD
Dextroamphetamine—Diarrhoea—Cisplatin—testicular cancer	0.0014	0.0021	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Epirubicin—testicular cancer	0.0014	0.0021	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Etoposide—testicular cancer	0.00138	0.00208	CcSEcCtD
Dextroamphetamine—Asthenia—Etoposide—testicular cancer	0.00135	0.00202	CcSEcCtD
Dextroamphetamine—Vomiting—Cisplatin—testicular cancer	0.0013	0.00195	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Doxorubicin—testicular cancer	0.00129	0.00194	CcSEcCtD
Dextroamphetamine—Rash—Cisplatin—testicular cancer	0.00129	0.00194	CcSEcCtD
Dextroamphetamine—Dermatitis—Cisplatin—testicular cancer	0.00129	0.00194	CcSEcCtD
Dextroamphetamine—Diarrhoea—Etoposide—testicular cancer	0.00128	0.00193	CcSEcCtD
Dextroamphetamine—Tension—Epirubicin—testicular cancer	0.00126	0.0019	CcSEcCtD
Dextroamphetamine—Nervousness—Epirubicin—testicular cancer	0.00125	0.00188	CcSEcCtD
Dextroamphetamine—Dizziness—Etoposide—testicular cancer	0.00124	0.00186	CcSEcCtD
Dextroamphetamine—Nausea—Cisplatin—testicular cancer	0.00122	0.00183	CcSEcCtD
Dextroamphetamine—Convulsion—Methotrexate—testicular cancer	0.00119	0.00179	CcSEcCtD
Dextroamphetamine—Vomiting—Etoposide—testicular cancer	0.00119	0.00179	CcSEcCtD
Dextroamphetamine—Agitation—Epirubicin—testicular cancer	0.00118	0.00178	CcSEcCtD
Dextroamphetamine—Rash—Etoposide—testicular cancer	0.00118	0.00178	CcSEcCtD
Dextroamphetamine—Dermatitis—Etoposide—testicular cancer	0.00118	0.00177	CcSEcCtD
Dextroamphetamine—Headache—Etoposide—testicular cancer	0.00118	0.00176	CcSEcCtD
Dextroamphetamine—Chest pain—Methotrexate—testicular cancer	0.00117	0.00176	CcSEcCtD
Dextroamphetamine—Tension—Doxorubicin—testicular cancer	0.00117	0.00176	CcSEcCtD
Dextroamphetamine—Nervousness—Doxorubicin—testicular cancer	0.00116	0.00174	CcSEcCtD
Dextroamphetamine—Palpitations—Epirubicin—testicular cancer	0.00114	0.00171	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Methotrexate—testicular cancer	0.00112	0.00169	CcSEcCtD
Dextroamphetamine—Convulsion—Epirubicin—testicular cancer	0.00112	0.00168	CcSEcCtD
Dextroamphetamine—Infection—Methotrexate—testicular cancer	0.00112	0.00168	CcSEcCtD
Dextroamphetamine—Nausea—Etoposide—testicular cancer	0.00111	0.00167	CcSEcCtD
Dextroamphetamine—Hypertension—Epirubicin—testicular cancer	0.00111	0.00167	CcSEcCtD
Dextroamphetamine—Chest pain—Epirubicin—testicular cancer	0.0011	0.00165	CcSEcCtD
Dextroamphetamine—Agitation—Doxorubicin—testicular cancer	0.0011	0.00164	CcSEcCtD
Dextroamphetamine—Anxiety—Epirubicin—testicular cancer	0.00109	0.00164	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Methotrexate—testicular cancer	0.00109	0.00163	CcSEcCtD
Dextroamphetamine—Dry mouth—Epirubicin—testicular cancer	0.00107	0.00161	CcSEcCtD
Dextroamphetamine—Anorexia—Methotrexate—testicular cancer	0.00107	0.00161	CcSEcCtD
Dextroamphetamine—Palpitations—Doxorubicin—testicular cancer	0.00105	0.00158	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Epirubicin—testicular cancer	0.00105	0.00158	CcSEcCtD
Dextroamphetamine—Infection—Epirubicin—testicular cancer	0.00104	0.00157	CcSEcCtD
Dextroamphetamine—Convulsion—Doxorubicin—testicular cancer	0.00103	0.00155	CcSEcCtD
Dextroamphetamine—Hypertension—Doxorubicin—testicular cancer	0.00103	0.00155	CcSEcCtD
Dextroamphetamine—Tachycardia—Epirubicin—testicular cancer	0.00103	0.00154	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Epirubicin—testicular cancer	0.00102	0.00153	CcSEcCtD
Dextroamphetamine—Insomnia—Methotrexate—testicular cancer	0.00102	0.00153	CcSEcCtD
Dextroamphetamine—Chest pain—Doxorubicin—testicular cancer	0.00101	0.00152	CcSEcCtD
Dextroamphetamine—Anxiety—Doxorubicin—testicular cancer	0.00101	0.00152	CcSEcCtD
Dextroamphetamine—Anorexia—Epirubicin—testicular cancer	0.001	0.00151	CcSEcCtD
Dextroamphetamine—Dyspnoea—Methotrexate—testicular cancer	0.001	0.0015	CcSEcCtD
Dextroamphetamine—Somnolence—Methotrexate—testicular cancer	0.000999	0.0015	CcSEcCtD
Dextroamphetamine—Dry mouth—Doxorubicin—testicular cancer	0.000993	0.00149	CcSEcCtD
Dextroamphetamine—Dyspepsia—Methotrexate—testicular cancer	0.000989	0.00149	CcSEcCtD
Dextroamphetamine—Decreased appetite—Methotrexate—testicular cancer	0.000977	0.00147	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000973	0.00146	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00097	0.00146	CcSEcCtD
Dextroamphetamine—Fatigue—Methotrexate—testicular cancer	0.000969	0.00145	CcSEcCtD
Dextroamphetamine—Infection—Doxorubicin—testicular cancer	0.000967	0.00145	CcSEcCtD
Dextroamphetamine—Insomnia—Epirubicin—testicular cancer	0.000951	0.00143	CcSEcCtD
Dextroamphetamine—Tachycardia—Doxorubicin—testicular cancer	0.00095	0.00143	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000941	0.00141	CcSEcCtD
Dextroamphetamine—Dyspnoea—Epirubicin—testicular cancer	0.000937	0.00141	CcSEcCtD
Dextroamphetamine—Somnolence—Epirubicin—testicular cancer	0.000935	0.0014	CcSEcCtD
Dextroamphetamine—Anorexia—Doxorubicin—testicular cancer	0.000927	0.00139	CcSEcCtD
Dextroamphetamine—Dyspepsia—Epirubicin—testicular cancer	0.000926	0.00139	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000919	0.00138	CcSEcCtD
Dextroamphetamine—Decreased appetite—Epirubicin—testicular cancer	0.000914	0.00137	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000908	0.00136	CcSEcCtD
Dextroamphetamine—Fatigue—Epirubicin—testicular cancer	0.000907	0.00136	CcSEcCtD
Dextroamphetamine—Constipation—Epirubicin—testicular cancer	0.000899	0.00135	CcSEcCtD
Dextroamphetamine—Urticaria—Methotrexate—testicular cancer	0.000893	0.00134	CcSEcCtD
Dextroamphetamine—Abdominal pain—Methotrexate—testicular cancer	0.000888	0.00133	CcSEcCtD
Dextroamphetamine—Body temperature increased—Methotrexate—testicular cancer	0.000888	0.00133	CcSEcCtD
Dextroamphetamine—Insomnia—Doxorubicin—testicular cancer	0.00088	0.00132	CcSEcCtD
Dextroamphetamine—Dyspnoea—Doxorubicin—testicular cancer	0.000867	0.0013	CcSEcCtD
Dextroamphetamine—Somnolence—Doxorubicin—testicular cancer	0.000865	0.0013	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Epirubicin—testicular cancer	0.00086	0.00129	CcSEcCtD
Dextroamphetamine—Dyspepsia—Doxorubicin—testicular cancer	0.000856	0.00129	CcSEcCtD
Dextroamphetamine—Decreased appetite—Doxorubicin—testicular cancer	0.000846	0.00127	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00084	0.00126	CcSEcCtD
Dextroamphetamine—Fatigue—Doxorubicin—testicular cancer	0.000839	0.00126	CcSEcCtD
Dextroamphetamine—Urticaria—Epirubicin—testicular cancer	0.000835	0.00125	CcSEcCtD
Dextroamphetamine—Constipation—Doxorubicin—testicular cancer	0.000832	0.00125	CcSEcCtD
Dextroamphetamine—Body temperature increased—Epirubicin—testicular cancer	0.000831	0.00125	CcSEcCtD
Dextroamphetamine—Abdominal pain—Epirubicin—testicular cancer	0.000831	0.00125	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Methotrexate—testicular cancer	0.000828	0.00124	CcSEcCtD
Dextroamphetamine—Asthenia—Methotrexate—testicular cancer	0.000806	0.00121	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000796	0.00119	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Epirubicin—testicular cancer	0.000775	0.00116	CcSEcCtD
Dextroamphetamine—Urticaria—Doxorubicin—testicular cancer	0.000773	0.00116	CcSEcCtD
Dextroamphetamine—Body temperature increased—Doxorubicin—testicular cancer	0.000769	0.00115	CcSEcCtD
Dextroamphetamine—Abdominal pain—Doxorubicin—testicular cancer	0.000769	0.00115	CcSEcCtD
Dextroamphetamine—Diarrhoea—Methotrexate—testicular cancer	0.000769	0.00115	CcSEcCtD
Dextroamphetamine—Asthenia—Epirubicin—testicular cancer	0.000754	0.00113	CcSEcCtD
Dextroamphetamine—Dizziness—Methotrexate—testicular cancer	0.000743	0.00112	CcSEcCtD
Dextroamphetamine—Diarrhoea—Epirubicin—testicular cancer	0.000719	0.00108	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Doxorubicin—testicular cancer	0.000717	0.00108	CcSEcCtD
Dextroamphetamine—Vomiting—Methotrexate—testicular cancer	0.000714	0.00107	CcSEcCtD
Dextroamphetamine—Rash—Methotrexate—testicular cancer	0.000708	0.00106	CcSEcCtD
Dextroamphetamine—Dermatitis—Methotrexate—testicular cancer	0.000708	0.00106	CcSEcCtD
Dextroamphetamine—Headache—Methotrexate—testicular cancer	0.000704	0.00106	CcSEcCtD
Dextroamphetamine—Asthenia—Doxorubicin—testicular cancer	0.000698	0.00105	CcSEcCtD
Dextroamphetamine—Dizziness—Epirubicin—testicular cancer	0.000695	0.00104	CcSEcCtD
Dextroamphetamine—Vomiting—Epirubicin—testicular cancer	0.000669	0.001	CcSEcCtD
Dextroamphetamine—Nausea—Methotrexate—testicular cancer	0.000667	0.001	CcSEcCtD
Dextroamphetamine—Diarrhoea—Doxorubicin—testicular cancer	0.000666	0.001	CcSEcCtD
Dextroamphetamine—Rash—Epirubicin—testicular cancer	0.000663	0.000996	CcSEcCtD
Dextroamphetamine—Dermatitis—Epirubicin—testicular cancer	0.000662	0.000995	CcSEcCtD
Dextroamphetamine—Headache—Epirubicin—testicular cancer	0.000659	0.000989	CcSEcCtD
Dextroamphetamine—Dizziness—Doxorubicin—testicular cancer	0.000643	0.000966	CcSEcCtD
Dextroamphetamine—Nausea—Epirubicin—testicular cancer	0.000625	0.000938	CcSEcCtD
Dextroamphetamine—Vomiting—Doxorubicin—testicular cancer	0.000619	0.000929	CcSEcCtD
Dextroamphetamine—Rash—Doxorubicin—testicular cancer	0.000613	0.000921	CcSEcCtD
Dextroamphetamine—Dermatitis—Doxorubicin—testicular cancer	0.000613	0.00092	CcSEcCtD
Dextroamphetamine—Headache—Doxorubicin—testicular cancer	0.00061	0.000915	CcSEcCtD
Dextroamphetamine—Nausea—Doxorubicin—testicular cancer	0.000578	0.000868	CcSEcCtD
